Type not reported
Azienda Unita Sanitaria Locale Di Bologna
Total Trials
4
Recruiting
0
Active
0
Completed
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Late-Stage Pipeline
100%
4 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed trials have results
Key Signals
Enrollment reporting
Analytics
Phase 4
2(50.0%)
Phase 3
2(50.0%)
4Total
Phase 4(2)
Phase 3(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT05300672Phase 3Completed
Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis (FibER)
Role: lead
NCT06471231Phase 4Unknown
Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock
Role: lead
SYFb999e3ef5e074afd9da411d9527a6e2ePhase 4Not Yet Recruiting
Tailored antiplatelet secondary prevention in non-cardioembolic ischemic stroke: a phase IV gender-stratified randomized controlled trial (TAILOR trial)
Role: lead
SYFd41e5b5fe66a44bfaa4e1ad54bb6d9a7Phase 3Not Yet Recruiting
Surgical versus Medical Treatment in Microprolactinomas (SUMET PRO)
Role: lead
All 4 trials loaded